Taurine clinical trials
Taurine is named as an intervention in 3 current clinical trials in our China and Canada registers. 3 are recruiting patients now. The most common phase is Phase 2. The sponsor with the most trials is Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University (1). The most-studied condition is Radiation Induced Oral Mucositis.
Where Taurine is approved
All regulators →- 1 EU orphan designation, most recently for treatment of maple syrup urine disease (26 Oct 2018, positive)
From the regulators' own registers: FDA Drugs@FDA, the EMA medicines list and Health Canada's Notice of Compliance database. Dates are the first listed approval of a product containing only this substance; combination products and nationally authorised EU medicines are not counted.
What health systems spend on Taurine
All medicines →From NHSBSA Prescription Cost Analysis (Open Government Licence v3.0) and CMS State Drug Utilization Data. Both are gross amounts: neither system publishes its discounts or rebates per drug. Products combining several substances are not counted here.
How Taurine works
All drug targets →- Hypertensive disorderPhase 3
- XerostomiaPhase 3
- FatiguePhase 2/3
- Long COVID-19Phase 2/3
- Peripartum cardiomyopathyPhase 2/3
- Psychotic disorderPhase 2/3
- Bipolar disorderPhase 2
- DermatitisPhase 2
- Gastric cancerPhase 2
- Multiple sclerosis symptom measurementPhase 2
Mechanisms and diseases from ChEMBL via the Open Targets Platform (release 26.09), ChEMBL record CHEMBL239243, CC BY-SA 3.0. Targets checked against the IUPHAR/BPS Guide to PHARMACOLOGY (2026.3.1), ligand 2379, CC BY-SA 4.0. Trial phases are not approvals: approved uses are shown from the regulators' own records where we hold them.
Patient leaflets for Taurine
The package leaflet is the official guide for patients that comes with every medicine. These links go to the regulators that publish it.
- UKUnited Kingdom: Search MHRA ProductsPatient information leaflets and SmPCs for UK-licensed products.
- USUnited States: Search DailyMedFDA-approved labels, including patient and medication guides.
Leaflets differ between brands and countries; always read the one that comes with your own medicine. This is regulatory information, not medical advice.
Reference identifiers for Taurine
- ChEMBL
- CHEMBL239243
- DrugBank
- DB01956
- PubChem CID
- 4068592
- CAS number
- 107-35-7
- FDA UNII
- 1EQV5MLY3D
- Wikidata
- Q207051
- Wikipedia
- Taurine
Codes that identify this medicine in other databases, from Wikidata (CC0), matched by its ChEMBL ID. The ATC code is the WHO classification of what the medicine is used for.
Trials by status
Trials by phase
Clinical trials of Taurine
3 trials| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
Taurine Supplementation in Long COVID
NCT06721949 · ClinicalTrials.gov ↗ · Long COVID
|
Phase 2/3 | Recruiting | University of Alberta | Canada |
|
Taurine's Therapeutic Effect on Acute Radiation-induced Oral Mucositis and Dermatitis
NCT07029178 · ClinicalTrials.gov ↗ · Radiation Induced Oral Mucositis, Radiodermatitis
|
Phase 2 | Recruiting | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | China |
|
Taurine for the Prevention and Treatment of Radiation-induced Oral Mucositis in Patients With Nasopharyngeal Carcinoma
NCT07567742 · ClinicalTrials.gov ↗ · Oral Mucositis (Ulcerative) Due to Radiation, Nasopharyngeal Carcinoma (NPC)
|
Phase 2 | Recruiting | Sun Yat-sen University | China |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
Taurine across our data
Ireland · EU · USThe same active substance in our other registers, matched by its exact name. Each entry links to the register record it comes from.
Supply shortages
- Aminoven infant 10%Germany (BfArM) · Other reason · 19 Feb 2026 to 31 Dec 2026
- Aminoven infant 10%Germany (BfArM) · Other reason · 19 Feb 2026 to 31 Dec 2026
- Aminoven 10 %Germany (BfArM) · Other reason · 19 Feb 2026 to 31 Dec 2026
- Aminoven 10 %Germany (BfArM) · Other reason · 19 Feb 2026 to 31 Dec 2026
Conditions studied with Taurine
5 conditionsSponsors
lead sponsor per trial| Lead sponsor | Trials |
|---|---|
| Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 1 |
| Sun Yat-sen University | 1 |
| University of Alberta | 1 |
By country register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in China | 2 | 2 |
| Clinical trials in Canada | 1 | 1 |
A trial with sites in more than one country appears in each of those registers.
Questions about Taurine trials
How many clinical trials are testing Taurine?
3 current trials in our China and Canada registers name Taurine as a drug or biological intervention, as of the registry sync on 10 November 2026. Completed and withdrawn studies are not counted.
Are Taurine trials recruiting patients?
Yes. 3 of the 3 trials are recruiting: 2 with sites in China and 1 with sites in Canada. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Who sponsors Taurine clinical trials?
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University (1), Sun Yat-sen University (1) and University of Alberta (1). The number in brackets is how many trials each organisation leads.
Is there a Taurine shortage?
The registers we track list 4 entries for Taurine: 4 German notices. Shortages are product- and country-specific; check with a pharmacist.
Where does this information come from?
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Taurine works or whether it is effective, and it is not medical advice.
How this page is built
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Taurine works or whether it is effective. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, intervention names and synonyms, phase, overall status, lead sponsor and conditions for every trial on this page
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Taurine (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 10 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.